NEW YORK and BERLIN, Sept. 07, 2022 (GLOBE NEWSWIRE) — atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical firm aiming to remodel the therapy of psychological well being problems, will take part in the next investor conferences in September:
- Citi’s 17th Annual BioPharma Conference in Boston
Format: Industry Panel
Date and Time: Wednesday, September 7th, 10:30 a.m. ET – 11:15 a.m. ET
Conference Link: URL
- H.C. Wainwright’s 24th Annual Global Investment Conference in New York City
Format: Company Presentation
Date and Time: Tuesday, September 13th, 11:00 a.m. ET – 11:45 a.m. ET
Conference Link: URL
- Cowen’s 2nd Annual Novel Mechanisms in Neuropsychiatry Virtual Summit
Format: Industry Panel
Date and Time: Monday, September 19th, 3:05 p.m. ET – 4:05 p.m. ET | 4:15 p.m. ET – 5:15 p.m. ET
Conference Link: URL
- Jefferies’ 1st Annual Psychedelics/Emerging Novel Treatments for Mental Health Summit in New York City
Format: Company Presentation
Date and Time: Thursday, September 22nd, 9:30 a.m. ET – 10:15 a.m. ET
Link: TBA
The displays and archived webcasts may also be accessible in the Events part of atai’s web site the place they are going to be out there for up to 90 days.
About atai Life Sciences
atai Life Sciences is a clinical-stage biopharmaceutical firm aiming to remodel the therapy of psychological well being problems. Founded in 2018 as a response to the numerous unmet want and lack of innovation in the psychological well being therapy panorama, atai is devoted to buying, incubating, and effectively growing progressive therapeutics to deal with despair, anxiousness, habit, and different psychological well being problems.
By pooling assets and finest practices, atai goals to responsibly speed up the event of recent medicines throughout its corporations to obtain clinically significant and sustained behavioral change in psychological well being sufferers.
atai’s imaginative and prescient is to heal psychological well being problems so that everybody, in all places can dwell a extra fulfilled life. For extra info, please go to www.atai.life
Forward-Looking Statements
These displays might comprise forward-looking statements inside the that means of the Private Securities Litigation Reform Act of 1995. Any expressed or implied statements contained in these displays that aren’t statements of historic reality could also be deemed to be forward-looking statements. Forward-looking statements are neither guarantees nor ensures, however contain identified and unknown dangers and uncertainties that might trigger precise outcomes to differ materially from these projected, together with, with out limitation, the essential components described in the part titled “Risk Factors” in our most up-to-date Annual Report on Form 10-Okay filed with the Securities and Exchange Commission (“SEC”), as up to date by our subsequent filings with the SEC, as such components could also be up to date from time to time in atai’s different filings with the SEC. atai disclaims any obligation or endeavor to replace or revise any forward-looking statements contained in this press launch, aside from to the extent required by relevant regulation.
Contact Information
Investor Contact:
Stephen Bardin
Chief Financial Officer, atai Life Sciences
Email: [email protected]
Media Contact:
Allan Malievsky
Senior Director, External Affairs
Email: [email protected]
